These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Release of corticotropin-releasing factor from superfused rat hypothalami induced by interleukin-1 is not dependent on adrenergic mechanism. Cambronero JC; Rivas FJ; Borrell J; Guaza C Eur J Pharmacol; 1992 Aug; 219(1):75-80. PubMed ID: 1327836 [TBL] [Abstract][Full Text] [Related]
43. Stimulation electrically and by acetylcholine of the rat hypothalamus in vitro. Bradbury MW; Burden J; Hillhouse EW; Jones MT J Physiol; 1974 Jun; 239(2):269-83. PubMed ID: 4547308 [TBL] [Abstract][Full Text] [Related]
44. The nature of corticotropin releasing factor from rat hypothalamus in vitro. Jones MT; Gillham B; Hillhouse EW Fed Proc; 1977 Jul; 36(8):2104-9. PubMed ID: 17553 [No Abstract] [Full Text] [Related]
45. Effects of pyrogenic immunomodulators on the release of corticotrophin-releasing factor-41 and prostaglandin E2 from the intact rat hypothalamus in vitro. Milton NG; Self CH; Hillhouse EW Br J Pharmacol; 1993 May; 109(1):88-93. PubMed ID: 8495249 [TBL] [Abstract][Full Text] [Related]
46. [Hypothalamic control of ACTH secretion]. Oliver C; Conte-Devolx B; Giraud P; Gillioz P; Lissitzky JC; Boudouresque F Horm Res; 1980; 13(4-5):230-41. PubMed ID: 6268511 [TBL] [Abstract][Full Text] [Related]
47. Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticotrophin-releasing hormone and pituitary ACTH release in vitro. Calogero AE; Raiti F; Nicolosi G; Burrello N; D'Agata R; Mantero F J Endocrinol; 1994 Mar; 140(3):419-24. PubMed ID: 8182369 [TBL] [Abstract][Full Text] [Related]
48. Stimulation by interleukin-1 (IL-1) of the release of rat corticotropin-releasing factor (CRF), which is independent of the cholinergic mechanism, from superfused rat hypothalamo-neurohypophysial complexes. Ohgo S; Nakatsuru K; Oki Y; Ishikawa E; Matsukura S Brain Res; 1991 Jun; 550(2):213-9. PubMed ID: 1679371 [TBL] [Abstract][Full Text] [Related]
49. Ovine corticotrophin releasing factor stimulates ACTH release from human corticotrophinoma cells in culture; interaction with hydrocortisone and arginine vasopressin. White MC; Adams EF; Loizou M; Mashiter K; Fahlbusch R Clin Endocrinol (Oxf); 1985 Sep; 23(3):295-302. PubMed ID: 3000651 [TBL] [Abstract][Full Text] [Related]
50. Corticotropin-releasing factor (CRF) inhibits gonadotropin-releasing hormone (GnRH) release from superfused rat hypothalami in vitro. Nikolarakis KE; Almeida OF; Herz A Brain Res; 1986 Jul; 377(2):388-90. PubMed ID: 3524753 [TBL] [Abstract][Full Text] [Related]
51. The effect of various putative neurotransmitters on the release of corticotrophin releasing hormone from the hypothalamus of the rat in vitro. I. The effect of acetylcholine and noradrenaline. Hillhouse EW; Burden J; Jones MT Neuroendocrinology; 1975; 17(1):1-11. PubMed ID: 1079076 [TBL] [Abstract][Full Text] [Related]
52. Controls of corticotrophin-releasing factor output by hypothalamic tissue from fetal sheep in vitro. Brooks AN; Power LA; Jones SA; Yang KP; Challis JR J Endocrinol; 1989 Jul; 122(1):15-22. PubMed ID: 2788695 [TBL] [Abstract][Full Text] [Related]
53. ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF. Hirotani C; Oki Y; Ukai K; Okuno T; Kurasaki S; Ohyama T; Doi N; Sasaki K; Ase K Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):54-60. PubMed ID: 15645295 [TBL] [Abstract][Full Text] [Related]
54. Acetylcholine and norepinephrine stimulate the release of corticotropin-releasing factor-41 from the rat hypothalamus in vitro. Tsagarakis S; Holly JM; Rees LH; Besser GM; Grossman A Endocrinology; 1988 Oct; 123(4):1962-9. PubMed ID: 2970959 [TBL] [Abstract][Full Text] [Related]
55. Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats. Suemaru S; Hashimoto K; Ota Z Acta Med Okayama; 1985 Dec; 39(6):463-70. PubMed ID: 3004111 [TBL] [Abstract][Full Text] [Related]
56. ACTH secretory responsiveness of pituitary adrenotroph cell tumor to adrenocorticotropin-releasing factor in Cushing's disease and Nelson's syndrome. Takeda R; Ito T; Kawato M; Nakabayashi H; Miyamori I; Morise T; Koshida H; Ikeda M Exp Clin Endocrinol; 1986 Jun; 87(1):31-7. PubMed ID: 3017732 [TBL] [Abstract][Full Text] [Related]
57. ACTH response induced by interleukin-1 is mediated by CRF secretion stimulated by hypothalamic PGE. Watanabe T; Morimoto A; Sakata Y; Murakami N Experientia; 1990 May; 46(5):481-4. PubMed ID: 2161351 [TBL] [Abstract][Full Text] [Related]
58. Structure-activity relationships of corticosteroid feedback at the hypothalamic level. Jones MT; Hillhouse EW; Burden JL J Endocrinol; 1977 Sep; 74(3):415-24. PubMed ID: 303680 [TBL] [Abstract][Full Text] [Related]
59. Effects of luteinizing-hormone-releasing hormone, alpha-melanocyte-stimulating hormone, naloxone, dexamethasone and indomethacin on interleukin-2-induced corticotropin-releasing factor release. Karanth S; Lyson K; Aguila MC; McCann SM Neuroimmunomodulation; 1995; 2(3):166-73. PubMed ID: 8646567 [TBL] [Abstract][Full Text] [Related]
60. Effect of ovine corticotrophin releasing factor, bromocriptine, and dopamine on release of ACTH and beta-endorphin in a patient with Cushing's disease. Nakashima H; Hirata Y; Uchihashi M; Tomita M; Fujita T Acta Endocrinol (Copenh); 1985 May; 109(1):7-12. PubMed ID: 2988259 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]